Today: 22 April 2026
Dogecoin price rebounds to 15 cents as 2x DOGE ETF TXXD jumps in early 2026
6 January 2026
1 min read

Dogecoin price rebounds to 15 cents as 2x DOGE ETF TXXD jumps in early 2026

New York, Jan 6, 2026, 07:18 EST

  • Dogecoin rose about 2.9% to around $0.151 after slipping as low as $0.1465.
  • The 21Shares 2x Long Dogecoin ETF (TXXD) was up about 15.6% from its previous close.
  • Memecoin market value jumped more than 30% in four days, even as futures positioning showed mixed conviction.

Dogecoin traded near $0.151 on Tuesday, up about 2.9% on the day, after dipping to $0.1465, price data showed. The rally has spilled into leveraged products, with the 21Shares 2x Long Dogecoin ETF up about 15.6% from its previous close.

The move matters now because leveraged exchange-traded funds, or ETFs, can pull short-term money into volatile markets by promising a multiple of a daily price swing. A hot start for a Dogecoin-linked fund points to renewed risk-taking in memecoins after months of uneven trading.

Dogecoin has gained about 30% over the past four days as the wider memecoin category’s market capitalisation rose more than 30% to $47.8 billion, FXStreet reported. It also flagged a rebound from historically low “meme-to-altcoin dominance” — a measure of how much memecoins make up of the broader altcoin market. FXStreet

The 21Shares fund, ticker TXXD, aims to deliver twice Dogecoin’s daily performance and uses derivatives such as swaps and futures rather than holding DOGE directly, the issuer says. Because the leverage resets each day, performance over longer stretches can diverge sharply from a simple “two times” bet. 21Shares

“This new ETF gives investors a simplified way to participate in its growth,” Federico Brokate, 21Shares’ global head of business development, said in a statement when the product launched. Leveraged ETFs are typically marketed for short-term trading because daily compounding can magnify losses as well as gains. ETFGI

Derivatives traders have also increased exposure, though not in a straight line. Open interest in Dogecoin futures — an estimate of outstanding contracts — rose to 13.47 billion DOGE on Jan. 2 before easing to 12.68 billion DOGE, FXStreet said, citing Coinglass data.

On the charts, analysts are watching whether DOGE can break above about $0.166, a level highlighted as resistance, after moving above its 50-day exponential moving average — a trend gauge that weights recent prices more heavily. FXStreet said a drop below roughly $0.142 could bring $0.121 into view, while a push higher could test $0.181.

More aggressive targets have returned to the conversation. A technical study shared by crypto analyst Javon Marks argued that repeating past “altcoin season” moves — periods when smaller tokens outperform — would imply a $10 Dogecoin scenario, while also pointing to nearer milestones around $0.65 and $1.25. TradingView

The broader crypto market was also firmer. Bitcoin rose about 1% to $93,865 and ether gained roughly 2% to $3,240, price data showed.

But the same dynamics driving the surge can reverse quickly. Memecoins are prone to sharp swings driven by sentiment, and leveraged ETFs can amplify losses and erode in choppy markets because they rebalance daily.

Stock Market Today

  • Is BXP Stock a Smart Buy Ahead of Q1 Earnings Release?
    April 22, 2026, 1:31 PM EDT. BXP, Inc., a major office real estate investment trust (REIT), is set to report first-quarter 2026 earnings on April 28 after market close. The company is expected to show a year-over-year decline in revenues and funds from operations (FFO) per share. Despite recent misses against analyst estimates, BXP benefits from strong U.S. office market fundamentals, including robust demand for high-quality office spaces and declining supply. Industry reports highlight positive leasing trends, reduced sublease inventory, and an ongoing flight-to-quality trend favoring premium office locations. Investors will watch BXP's results closely amid these market dynamics to gauge recovery and growth potential ahead.

Latest article

US Stock Market Today: Nasdaq Leads Wall Street Rally as Iran Ceasefire Relief Meets Earnings Momentum

US Stock Market Today: Nasdaq Leads Wall Street Rally as Iran Ceasefire Relief Meets Earnings Momentum

22 April 2026
The Nasdaq rose 1.29% as technology and chip stocks led gains after President Trump extended the Iran ceasefire. GE Vernova, Boeing, and Boston Scientific advanced following earnings reports. Oil hovered near $100, with fresh ship seizures in the Strait of Hormuz highlighting ongoing risks. At 11:25 a.m. ET, the Dow was up 381 points, the S&P 500 gained 61 points, and the Nasdaq climbed 314 points.
Uber Now Owns 11.5% of Lucid. The Robotaxi Bet Is Bigger Than It Looked

Uber Now Owns 11.5% of Lucid. The Robotaxi Bet Is Bigger Than It Looked

22 April 2026
Uber disclosed an 11.52% passive stake in Lucid Group, owning 37.8 million shares through a subsidiary, according to an SEC filing dated April 20. The move follows Uber’s expanded $500 million investment and a commitment to purchase at least 35,000 Lucid robotaxi vehicles. Lucid shares fell 1.3% Wednesday after a prior rally. The companies plan a commercial robotaxi launch in the Bay Area later this year.
Super Micro Stock Climbs Before Earnings As Options Traders Price An 11% Swing

Super Micro Stock Climbs Before Earnings As Options Traders Price An 11% Swing

22 April 2026
Super Micro shares rose 2.7% to $29.20 Wednesday morning, extending a rebound ahead of its May 5 earnings report. Options markets are pricing in high volatility, with a 50% chance of a move larger than 10.99% around the results. The report follows a March indictment tied to export controls and compliance concerns. JPMorgan last week cut its price target to $28.
Mortgage Refi Rates Hover Near 6.24% as 2026 Starts—Here’s What’s Driving the Numbers
Previous Story

Mortgage Refi Rates Hover Near 6.24% as 2026 Starts—Here’s What’s Driving the Numbers

AbbVie stock flat premarket after Canada OKs Maviret for acute hepatitis C — what investors watch next
Next Story

AbbVie stock flat premarket after Canada OKs Maviret for acute hepatitis C — what investors watch next

Go toTop